3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Squamous Cell Carcinoma of Head and Neck
2
Carcinoma, Non-Small-Cell Lung
2
Triple Negative Breast Neoplasms
1
Tracheal Diseases
1
Small Cell Lung Carcinoma
1
Salivary Gland Neoplasms
1
Recurrence
1
Pancreatic Neoplasms
1
Neuroblastoma
1
Neoplasm Metastasis
1
Mesothelioma, Malignant
1
Mesothelioma
1
Lymphoma, Large B-Cell, Diffuse
1
Lung Neoplasms
1
Laryngeal Diseases
1
Head and Neck Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Carcinoma, Adenoid Cystic
1
Breast Neoplasms
1
Advanced or Metastatic Solid Tumors
1
Interventions
pembrolizumab
4
envafolimab
2
tebentafusp
1
TAK-981
1
Nivolumab
1
Injections
1
Doxorubicin
1
Combined Modality Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Advanced or Metastatic Solid Tumors
×
Combined Modality Therapy
×
1 year
×
Clear all
NCT05957081
2025-12-30
MarkV-01
PharmAbcine
Phase 1
Recruiting
67 enrolled